Breaking News

Avirmax CMC Launches AAV Production with Sf Rhabdovirus-free Cell Lines

The Sf9 cell rAAV production system has been shown to produce high yields of rAAV products containing vector genomes.

Avirmax CMC Inc. a cGMP-licensed contract development and manufacturing organization (CDMO), implemented its newly developed Sf rhabdovirus-free cell lines (under the generic trademark of Sf-RVF) developed for producing recombinant adeno-associated viral vectors (rAAV). As an insect cell line derived from the ovarian tissue of Spodoptera frugiperda (Sf), the Sf9 cell line in concert with recombinant baculoviruses, has been widely utilized for manufacturing biologics, including recombinant pro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters